All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

XBiotech Inc. revenue reports

XBiotech Inc. financial reports, XBiotech Inc. annual revenue in 2024. When does XBiotech Inc. report revenue?
Add to widgets
Added to widgets

XBiotech Inc. total revenue, net income and dynamics of changes in US dollar today

Net revenue XBiotech Inc. is now 4 850 000 $. Information about net revenue is taken from open sources. The dynamics of XBiotech Inc. net revenue decreased by -419 000 $ from the last reporting period. The dynamics of XBiotech Inc. net income fell by -730 000 $ for the last reporting period. Chart of online financial report of XBiotech Inc.. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. XBiotech Inc. financial report on the graph shows the dynamics of assets.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 4 850 000 $ - -2 568 000 $ -
31/12/2020 5 269 000 $ - -1 838 000 $ -
30/09/2020 10 549 000 $ - -2 526 000 $ -
30/06/2020 15 498 000 $ - -6 844 000 $ -
30/09/2019 0 $ - -6 150 000 $ -
30/06/2019 0 $ - -5 852 000 $ -
31/03/2019 0 $ - -5 864 000 $ -
31/12/2018 0 $ - -6 111 000 $ -
30/09/2018 0 $ - -5 051 000 $ -
30/06/2018 0 $ - -5 907 000 $ -
31/03/2018 0 $ - -4 069 000 $ -
31/12/2017 0 $ - -7 249 000 $ -
30/09/2017 0 $ - -6 205 000 $ -
30/06/2017 0 $ - -9 133 000 $ -
Show:
to

XBiotech Inc. financial report charts

The dates of the latest financial statements of XBiotech Inc.: 30/06/2017, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of XBiotech Inc. is 31/03/2021. Gross profit XBiotech Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit XBiotech Inc. is 2 546 000 $

XBiotech Inc. quarterly report dates

Cost of revenue XBiotech Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue XBiotech Inc. is 2 304 000 $ Total revenue XBiotech Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue XBiotech Inc. is 4 850 000 $ Operating income XBiotech Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income XBiotech Inc. is -3 553 000 $

Net income XBiotech Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income XBiotech Inc. is -2 568 000 $ Current assets XBiotech Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets XBiotech Inc. is 327 899 000 $ Total assets XBiotech Inc. refers to the total amount of assets owned by a person or entity. Total assets XBiotech Inc. is 355 940 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
2 546 000 $ 3 021 000 $ 1 123 000 $ 2 297 000 $ - - - - - - - - - -
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 304 000 $ 2 248 000 $ 9 426 000 $ 13 201 000 $ - - - - - - - - - -
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
4 850 000 $ 5 269 000 $ 10 549 000 $ 15 498 000 $ - - - - - - - - - -
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-3 553 000 $ -4 922 000 $ -4 670 000 $ -6 514 000 $ -6 111 000 $ -6 006 000 $ -5 805 000 $ -6 108 000 $ -5 115 000 $ -5 621 000 $ -4 150 000 $ -7 506 000 $ -6 593 000 $ -9 688 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-2 568 000 $ -1 838 000 $ -2 526 000 $ -6 844 000 $ -6 150 000 $ -5 852 000 $ -5 864 000 $ -6 111 000 $ -5 051 000 $ -5 907 000 $ -4 069 000 $ -7 249 000 $ -6 205 000 $ -9 133 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
4 634 000 $ 3 461 000 $ 2 346 000 $ 2 565 000 $ 4 533 000 $ 4 693 000 $ 4 527 000 $ 4 650 000 $ 3 940 000 $ 3 756 000 $ 2 993 000 $ 5 906 000 $ 4 930 000 $ 7 399 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
8 403 000 $ 10 191 000 $ 15 219 000 $ 22 012 000 $ 6 111 000 $ 6 006 000 $ 5 805 000 $ 6 108 000 $ 5 115 000 $ 5 621 000 $ 4 150 000 $ 7 506 000 $ 6 593 000 $ 9 688 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
327 899 000 $ 325 875 000 $ 251 685 000 $ 258 389 000 $ 40 911 000 $ 45 599 000 $ 12 982 000 $ 17 016 000 $ 21 306 000 $ 25 766 000 $ 29 749 000 $ 33 332 000 $ 40 289 000 $ 47 301 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
355 940 000 $ 353 744 000 $ 353 393 000 $ 358 762 000 $ 66 643 000 $ 71 875 000 $ 39 824 000 $ 44 345 000 $ 49 244 000 $ 54 290 000 $ 58 860 000 $ 62 972 000 $ 70 671 000 $ 77 841 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
239 879 000 $ 237 366 000 $ 238 431 000 $ 229 703 000 $ 40 338 000 $ 44 921 000 $ 12 019 000 $ 15 823 000 $ 20 849 000 $ 24 849 000 $ 28 416 000 $ 31 768 000 $ 38 977 000 $ 45 949 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 2 021 000 $ 2 462 000 $ 2 841 000 $ 2 944 000 $ 2 300 000 $ 2 756 000 $ - - - -
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - 28 416 000 $ 31 768 000 $ 38 977 000 $ 45 949 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 2 021 000 $ 2 462 000 $ 2 841 000 $ 2 947 000 $ 2 307 000 $ 2 768 000 $ - - - -
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 3.03 % 3.43 % 7.13 % 6.65 % 4.68 % 5.10 % - - - -
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
352 098 000 $ 348 639 000 $ 346 139 000 $ 343 570 000 $ 64 622 000 $ 69 413 000 $ 36 983 000 $ 41 398 000 $ 46 937 000 $ 51 522 000 $ 56 410 000 $ 60 162 000 $ 67 149 000 $ 73 156 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -4 984 000 $ -4 863 000 $ -4 677 000 $ -5 116 000 $ -3 995 000 $ -3 900 000 $ -3 526 000 $ -6 807 000 $ -6 466 000 $ -8 468 000 $

Last revenue report of XBiotech Inc. was 31/03/2021. According to last financial report total revenue in XBiotech Inc. was 4 850 000 US dollar and changed by 0% since last year. Net income in XBiotech Inc. was -2 568 000 $ in last quartal, net income changes to 0%.

Current cash XBiotech Inc. - the sum of all of the cash a company has on the date of report. Current cash XBiotech Inc. is 239 879 000 $

XBiotech Inc. stocks data

XBiotech Inc. financials